Full Text (PDF)
Original Article

A Comparative Study of the Effects of Intrathecal Levobupivacaine Vs Ropivacaine for Inguinal Hernioplasty

Dr. R. Gowthaman, Professor, Dept. of Anaesthesia, Annamalai University, Rajah Muthiah Medical College, Chidambaram, Tamilnadu 608002, India , R. Gowthaman1 , V. Haribabu2

Author Information

Licence:




Indian Journal of Anesthesia and Analgesia 5(2):p 303-309, February 2018. | DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.5218.25

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Objective: To compare the onset and duration of sensory and motor block, haemodynamic responses, side effects associated with administration of intrathecal isobaric levobupivacaine (0.5%) and isobaric ropivacaine(0.75%) for inguinal hernioplasty. Place and Duration of Study: Rajah Muthaih Medical College, Chidambaram, 2016-17. Methodology: After obtaining approval from institutional ethics committee and written informed consent from all patients, a randomized controlled double blinded clinical trial was conducted on 50 ASA 1 and 2 adult patients undergoing elective inguinal hernioplasty. Patients were randomly allocated into two groups, group L and group R of 25 each. Patients in group L were to receive isobaric levobupivacaine 0.5% and group R 0.75% ropivacaine. Haemodynamic variables (heart rate, systolic and diastolic BP) and onset and duration of sensory and motor block, sensory regression time were recorded and compared.


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI: http://dx.doi.org/10.21088/ijaa.2349.8471.5218.25

Keywords

Levobupivacaine; Ropivacaine; Randomized Control Trial; Double Blinded Study.

Article Level Metrics

Last Updated

Tuesday 14 July 2026, 07:47:27 (IST)


5689

Accesses

3
679
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share